Theravance Inc news

   Watch this stock
Showing stories 1 - 7 of about 7   

Articles published

THRX 16.46 -0.13 (-0.78%)
price chart
Theravance licenses antibiotic tech to Hospira
(Reuters) - Biopharmaceutical company Theravance Inc said it licensed its technology to manufacture antibiotic Vibativ to specialty medicines maker Hospira Inc. The company would purchase from Hospira more than a majority of its Vibativ 750 mg dosage ...
Related articles »  
GlaxoSmithKline boosts Theravance stake
Following approval Tuesday by Theravance stockholders, GSK's previously announced acquisition of 10 million shares of Theravance is now complete - meaning GSK owns 25.8 million shares of Theravance common stock. That's 26.7 percent of the total ...
Related articles »  
Obama, Romney 'shake the trees' in California
Dennis Driver of Sacramento, a vice president of the Bay Area biopharmaceutical company Theravance Inc., increased his donation to Obama to $2,500 this year, up from $500 in 2008.
Related articles »  
Tracking Seth Klarman's Baupost Group Holdings: Q1 2012 Update
Theravance Inc (NASDAQ:THRX): THRX, approximately 10% of the US long portfolio position, was increased marginally this quarter.
Related articles »  
Seth Klarman Betting Big On These 2 Stocks
Seth Klarman's Baupost Group is one of the largest hedge funds and regarded very highly in the world of "Graham-Dodd" value investors.
Related articles »  
Glaxo Diabetes Drug Data Revealed Amid Hostile Takeover
May 25 (Bloomberg) -- GlaxoSmithKline Plc will reveal detailed results today on an experimental treatment for diabetes that's part of the reason for a $2.6 billion hostile takeover bid for Human Genome Sciences Inc., its partner on the drug. Glaxo will ...
Related articles »  
Airline Stocks: Virgin America Takes Their Time With IPO
As market conditions continue to improve, airline company Virgin American is seeking to launch an IPO for 2013. The exact timing of the IPO still remains to be a looming question.
Related articles »